Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research
Roche today announced the global commercial launch of three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits – the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit.
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Pharmaceuticals